These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38669557)

  • 1. Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.
    Schaeffer E; Kluge A; Schulte C; Deuschle C; Bunk J; Welzel J; Maetzler W; Berg D
    J Parkinsons Dis; 2024; 14(4):667-679. PubMed ID: 38669557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
    Kluge A; Schaeffer E; Bunk J; Sommerauer M; Röttgen S; Schulte C; Roeben B; von Thaler AK; Welzel J; Lucius R; Heinzel S; Xiang W; Eschweiler GW; Maetzler W; Suenkel U; Berg D
    Mov Disord; 2024 Aug; 39(8):1289-1299. PubMed ID: 38651526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease.
    Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q
    Acta Neuropathol Commun; 2024 Oct; 12(1):167. PubMed ID: 39439002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
    Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
    Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
    Jiang C; Hopfner F; Katsikoudi A; Hein R; Catli C; Evetts S; Huang Y; Wang H; Ryder JW; Kuhlenbaeumer G; Deuschl G; Padovani A; Berg D; Borroni B; Hu MT; Davis JJ; Tofaris GK
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):720-729. PubMed ID: 32273329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson's disease.
    Mao H; Kuang Y; Feng D; Chen X; Lu L; Xia W; Gan T; Huang W; Guo W; Yi H; Yang Y; Wu Z; Dai W; Sun H; Wu J; Zhang R; Zhang S; Lin X; Yong Y; Yang X; Li H; Wu W; Huang X; Bian Z; Wong HLX; Wang XL; Poppell M; Ren Y; Liu C; Zou WQ; Chen S; Xu PY
    Transl Neurodegener; 2024 Jul; 13(1):35. PubMed ID: 39049095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.
    Si X; Tian J; Chen Y; Yan Y; Pu J; Zhang B
    Neuroscience; 2019 Aug; 413():308-316. PubMed ID: 31102760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.
    Kluge A; Borsche M; Streubel-Gallasch L; Gül T; Schaake S; Balck A; Prasuhn J; Campbell P; Morris HR; Schapira AH; Lohmann K; Brüggemann N; Rakovic A; Seibler P; Başak AN; Berg D; Klein C
    Ann Neurol; 2024 Jun; 95(6):1173-1177. PubMed ID: 38546204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of neuron-derived pathological α-synuclein in blood.
    Kluge A; Bunk J; Schaeffer E; Drobny A; Xiang W; Knacke H; Bub S; Lückstädt W; Arnold P; Lucius R; Berg D; Zunke F
    Brain; 2022 Sep; 145(9):3058-3071. PubMed ID: 35722765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy.
    Luan M; Wei L; Sun Y; Chen J; Jiang Y; Wu W; Li F; Sun W; Zhu L; Wang Z; Deng J
    Parkinsonism Relat Disord; 2024 Oct; 127():107088. PubMed ID: 39111257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.
    Kang UJ; Boehme AK; Fairfoul G; Shahnawaz M; Ma TC; Hutten SJ; Green A; Soto C
    Mov Disord; 2019 Apr; 34(4):536-544. PubMed ID: 30840785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
    Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T
    Mov Disord; 2024 Aug; 39(8):1300-1309. PubMed ID: 38715177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.
    Zimmermann M; Fandrich M; Jakobi M; Röben B; Wurster I; Lerche S; Schulte C; Zimmermann S; Deuschle C; Schneiderhan-Marra N; Joos TO; Gasser T; Brockmann K
    J Parkinsons Dis; 2024; 14(7):1405-1416. PubMed ID: 39240648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
    Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
    Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.